These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 9403093)
1. [Thrombolysis: Reteplase as an innovative alternative]. Z Kardiol; 1997 Oct; 86(10 Suppl):1-4. PubMed ID: 9403093 [No Abstract] [Full Text] [Related]
2. [Structure of the natural plasminogen activator (t-PA) and of reteplase. Controversies on thrombolytic therapy. 45th yearly session of the American College of Cardiology. Orlando, Fla. March 1996]. Dtsch Med Wochenschr; 1996; 121(36 Suppl Fur Praxis):1-8. PubMed ID: 9401482 [No Abstract] [Full Text] [Related]
3. Reteplase set to enter thrombolytic market. Am J Health Syst Pharm; 1997 Jan; 54(1):12. PubMed ID: 9117779 [No Abstract] [Full Text] [Related]
4. Reteplase (Retavase). Med Lett Drugs Ther; 1997 Feb; 39(995):17-8. PubMed ID: 9057777 [No Abstract] [Full Text] [Related]
6. Clinical trial results with a new plasminogen activator. Bode C; Peter K; Moser M; Smalling RW; Weaver WD Eur Heart J; 1997 Dec; 18 Suppl F():F17-21. PubMed ID: 9447336 [TBL] [Abstract][Full Text] [Related]
7. Validity of the GUSTO trial's main conclusion. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronaries. Eisenberg C Pharmacotherapy; 1997; 17(4):850-2. PubMed ID: 9250573 [No Abstract] [Full Text] [Related]
8. Controlled trials comparing reteplase with alteplase and streptokinase in patients with acute myocardial infarction. Amsterdam EA Pharmacotherapy; 1996; 16(5 Pt 2):137S-140S. PubMed ID: 8888101 [TBL] [Abstract][Full Text] [Related]
10. Reteplase but not alteplase affects early soluble PECAM-1 and P-selectin release in patients with acute myocardial infarction. Gurbel PA; Dalesandro MR; Serebruany VL Thromb Haemost; 1998 Oct; 80(4):725. PubMed ID: 9799011 [No Abstract] [Full Text] [Related]
11. Third generation plasminogen activators in the treatment of acute myocardial infarction. Talley JD J Ark Med Soc; 1996 Apr; 92(11):587-8. PubMed ID: 8675487 [No Abstract] [Full Text] [Related]
12. Thrombolysis with recombinant human single-chain urokinase-type plasminogen activator (rscu-PA): dose-response in dogs with coronary artery thrombosis. Van de Werf F; Jang IK; Collen D J Cardiovasc Pharmacol; 1987 Jan; 9(1):91-3. PubMed ID: 2434801 [TBL] [Abstract][Full Text] [Related]